Hepatitis C Virus Infection in Iran; Viral Spread Routes in General Population and Safety Measures

Authors

Muhammad Sohail Afzal1,*, Tahir Ahmad2, Haroon Ahmed3
1Department of Chemistry, School of Science, University of Management and Technology (UMT), Lahore, Pakistan
2Atta ur Rahman School of Applied Biosciences, National University of Science and Technology, Islamabad, Pakistan
3Department of Biosciences, COMSATS Institute of Information Technology, Islamabad, Pakistan
*Corresponding Author: Muhammad Sohail Afzal, Department of Chemistry, School of Science, University of Management and Technology (UMT), Lahore, Pakistan. Tel: +92-3215244808, Fax: +92-5190856102, E-mail: Email: [email protected]

Hepatitis Monthly:Vol. 15, issue 10; e17343
Published online:Oct 24, 2015
Article type:Letter
Received:Jan 02, 2014
Accepted:Jan 04, 2014
How to Cite:Afzal MS, Ahmad T, Ahmed H. Hepatitis C Virus Infection in Iran; Viral Spread Routes in General Population and Safety Measures. Hepat Mon. 2015;15(10):e17343. doi: https://doi.org/10.5812/hepatmon.17343

Dear Editor,
Hepatitis C virus (HCV) is the leading cause of liver related morbidity and mortality in the world; with more than 180 million infected patients (1). HCV prevalence is very low in Iran. The recent reports from Iran showed that HCV prevalence in general population was about 0.05% - 0.2% (2, 3). Due to globalization and traveling worldwide, especially to the neighboring countries, there is a chance of viral spread (4). The major factors involved in HCV spread are intravenous drug abuse, unhealthy medical practices, sharing contaminated objects such as needles and barbers' unawareness (5). Host factors are also involved in disease susceptibility, progression and viral self-clearance (6, 7). Recently, Zamani et al. (3) showed that unsterile punctures and history of infection in family members were associated with HCV spread. Despite obligatory blood screening for HCV, the prevalence of HCV infection raised dramatically in recent decades in the Middle-Eastern region. Currently, HCV prevalence in general Iranian population is very low; massive awareness campaigns should be done on a regular basis to educate general population to control the viral spread.

Footnotes

  • Authors’ Contributions:Study concept, design and manuscript drafting: Muhammad Sohail Afzal, Tahir Ahmad, Haroon Ahmed.

  • Funding/Support:The current study was supported by higher education commission of Pakistan.

References

  • 1.
    Anjum S, Ali S, Ahmad T, Afzal MS, Waheed Y, Shafi T, et al. Sequence and Structural Analysis of 3' Untranslated Region of Hepatitis C Virus, Genotype 3a, From Pakistani Isolates. Hepat Mon. 2013;13(5). ee8390. [PubMed ID: 23922562]. https://doi.org/10.5812/hepatmon.8390.
  • 2.
    Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, et al. The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon. 2013;13(3). eee7723. [PubMed ID: 23745128]. https://doi.org/10.5812/hepatmon.7723.
  • 3.
    Zamani F, Sohrabi M, Poustchi H, Keyvani H, Saeedian FS, Ajdarkosh H, et al. Prevalence and Risk Factors of Hepatitis C Virus Infection in Amol City, North of Iran: A Population-Based Study (2008-2011). Hepat Mon. 2013;13(12). ee13313. [PubMed ID: 24358039]. https://doi.org/10.5812/hepatmon.13313.
  • 4.
    Afzal MS, Anjum S, Zaidi NUSS. Changing of HCV Clade Pattern in Iran; the Possible Means for Something Good. Hepat Mon. 2014;14(1). ee11879. [PubMed ID: 24497875]. https://doi.org/10.5812/hepatmon.11879.
  • 5.
    Afzal MS, Ahmed T, Zaidi NUSS. Comparison of HCV Prevalence in Pakistan and Iran; An Insight into Future. Hepat Mon. 2014;14(1). ee11466. [PubMed ID: 24497874]. https://doi.org/10.5812/hepatmon.11466.
  • 6.
    Afzal MS, Tahir S, Salman A, Baig TA, Shafi T, Zaidi NU, et al. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. J Infect Dev Ctries. 2011;5(6):473-9. [PubMed ID: 21727647].
  • 7.
    Afzal MS, Anjum S, Zaidi NUSS. Effect of Functional Interleukin-10 Polymorphism on Pegylated Interferon-α Plus Ribavirin Therapy Response in Chronic Hepatitis C Virus Patients Infected With 3a Genotype in Pakistani Population. Hepat Mon. 2013;13(6). ee10274. [PubMed ID: 24032042]. https://doi.org/10.5812/hepatmon.10274.

Copyright

Copyright © 2015, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Similar Articles

1
Oct
2009

Epidemiology of Hepatitis C in Iran and the World.

SM Alavian,
F Fallahian

Alavian S, Fallahian F. Epidemiology of Hepatitis C in Iran and the World.. Shiraz E-Med J. 2009;10(4):. doi:

12
Jan
2014

Comparison of HCV Prevalence in Pakistan and Iran; An Insight into Future

Muhammad Sohail Afzal,
Tahir Ahmed,
Najam us Sahar Sadaf Zaidi

Afzal MS, Ahmed T, Zaidi NUSS. Comparison of HCV Prevalence in Pakistan and Iran; An Insight into Future. Hepat Mon. 2014;14(1):e11466. doi: https://doi.org/10.5812/hepatmon.11466

30
Jun
2008

Seroepidemiology of Hepatitis C in Kermanshah (West of Iran, 2006)

Babak Sayad,
Fatemeh shamsedin Saeed,
Hossein Keyvani,
Mansour Rezaii,
Tannaz Asadi,
Siavash Vaziri
,et al.

Sayad B, Saeed F, Keyvani H, Rezaii M, Asadi T, et al. Seroepidemiology of Hepatitis C in Kermanshah (West of Iran, 2006). Hepat Mon. 2008;8(2):. doi:

23
Jun
2018
Knowledge, Distribution and Risk Factors of Hepatitis B and C Infection in High-risk Groups in Guilan Province, Iran

Knowledge, Distribution and Risk Factors of Hepatitis B and C Infection in High-risk Groups in Guilan Province, Iran

Farahnaz Joukar,
Fariborz Mansour-Ghanaei,
Mohammad Reza Naghipour,
Soheil Hassanipour

Joukar F, Mansour-Ghanaei F, Naghipour MR, Hassanipour S. Knowledge, Distribution and Risk Factors of Hepatitis B and C Infection in High-risk Groups in Guilan Province, Iran. Hepat Mon. 2018;18(8):e65870. doi: https://doi.org/10.5812/hepatmon.65870

15
Feb
2020
Epidemiology of Hepatitis C Virus Infection Among 1,959 Patients in Shiraz, Southern Iran, Between 1991 and 2016

Epidemiology of Hepatitis C Virus Infection Among 1,959 Patients in Shiraz, Southern Iran, Between 1991 and 2016

Amir Hossein Babaei,
Ali Reza Safarpour,
Mohammad Reza Fattahi,
Vida Ahmadi

Babaei AH, Safarpour AR, Fattahi MR, Ahmadi V. Epidemiology of Hepatitis C Virus Infection Among 1,959 Patients in Shiraz, Southern Iran, Between 1991 and 2016. Arch Clin Infect Dis. 2020;15(1):e98849. doi: https://doi.org/10.5812/archcid.98849

More by these authors

Muhammad Sohail AfzalPubMedScholar
Tahir AhmadPubMedScholar
Haroon AhmedPubMedScholar
Share
Cited by
Metrics